We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Medtech Petitions FDA for Permission to Change Dosage in ANDA for Generic Excedrin
Medtech Petitions FDA for Permission to Change Dosage in ANDA for Generic Excedrin
Medtech petitioned the FDA to allow the company to submit an ANDA for generic Excedrin in which the proposed product is in a dosage form different from the reference drug.